Tue, April 21, 2020

Madhu Kumar Initiated (APRE) at Buy and Held Target at $900 on, Apr 21st, 2020

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-900-on-apr-21st-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Madhu Kumar of Baird, Initiated "Aprea Therapeutics, Inc." (APRE) at Buy and Held Target at $900 on, Apr 21st, 2020.

Madhu has made no other calls on APRE in the last 4 months.



There is 1 other peer that has a rating on APRE. Out of the 1 peers that are also analyzing APRE, all agrees with Madhu's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Increased Target to $780 on, Wednesday, April 15th, 2020